Evidence map›Paper›PMID 34370579›Full record

ArticleAntimicrobial agents and chemotherapy2021

Emergence of Erythromycin Resistance Methyltransferases in Campylobacter coli Strains in France.

Quentin Jehanne, Lucie Bénéjat, Astrid Ducournau, Chloé Domingues-Martins, Théo Cousinou, Emilie Bessède, Philippe Lehours

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Increasing rates ofAntimicrobial agents and chemotherapy · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. SVR-flaA typing of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni strains isolated from poultry slaughterhouses in southern Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Quentin JehanneFrench National Reference Center for Campylobacters and Helicobacters, Bordeaux Hospital University Center, Bordeaux, France.
Lucie BénéjatFrench National Reference Center for Campylobacters and Helicobacters, Bordeaux Hospital University Center, Bordeaux, France.
Astrid DucournauFrench National Reference Center for Campylobacters and Helicobacters, Bordeaux Hospital University Center, Bordeaux, France.
Chloé Domingues-MartinsFrench National Reference Center for Campylobacters and Helicobacters, Bordeaux Hospital University Center, Bordeaux, France.
Théo CousinouFrench National Reference Center for Campylobacters and Helicobacters, Bordeaux Hospital University Center, Bordeaux, France.
Emilie BessèdeFrench National Reference Center for Campylobacters and Helicobacters, Bordeaux Hospital University Center, Bordeaux, France.
Philippe LehoursFrench National Reference Center for Campylobacters and Helicobacters, Bordeaux Hospital University Center, Bordeaux, France.ORCID 0000-0001-6077-1825
Université de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance in campylobacters has been described worldwide. The emergence of multiresistant isolates, particularly among Campylobacter coli isolates, is concerning. New resistance mechanisms appear frequently, and DNA-sequence-based methods such as whole-genome sequencing (WGS) have become useful tools to monitor their emergence. The genomes of 51 multiresistant French Campylobacter sp. clinical strains from 2018 to 2019 were analyzed to identify associated resistance mechanisms. Analyses of erythromycin-resistant strains revealed 23S rRNA mutations among most of them and two different methyltransferases in 4 strains: Erm(B) and a novel methyltransferase, named Erm(N) here. The

Indexed as

Campylobacter coliCampylobacter jejuniAnti-Bacterial AgentsDrug Resistance, BacterialErythromycinMacrolidesMethyltransferasesMicrobial Sensitivity TestsAnti-Bacterial AgentsErythromycinMacrolidesMethyltransferasesbioinformaticsCampylobactererythromycingenomicsmethyltransferaseresistance

Identifiers

PMID34370579
PMCPMC8522779
OpenAlexW3192290928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.